Search is Powered by Google
Cancer / Oncology News

Marijuana Does Not Increase Risk Of Head, Neck Cancer According To Small Study

Main Category: Cancer / Oncology
Also Included In: Alcohol / Addiction / Illegal Drugs
Article Date: 05 Mar 2008 - 2:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Smoking marijuana (cannabis) does not increase the user's risk of head and neck cancer, according to a new study published in the March 2008 issue of Otolaryngology - Head and Neck Surgery.

The small sample study, authored by researchers from New Zealand and Great Britain, found that among 75 cases of head and neck cancer, the relative risk of smoking cannabis and contracting head and neck cancer in marijuana users was the same (1.0) as in those who had never smoked cannabis. These results differ from the relative risk of contracting cancer from smoking cigarettes (2.1) and the heavy consumption of alcohol (5.7), compared with those who abstained from those activities.

However, due to the limits of the study, the authors cannot exclude other possible effects, and recommend a larger study.

Cancers of the head and neck, with more than 500,000 new cases diagnosed each year worldwide, represent the fourth most common type of cancer. It is estimated that more than 13,000 people will die from head and next cancer each year in the United States alone.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Otolaryngology - Head and Neck Surgery is the official scientific journal of the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS). The study authors are Sarah Aldington, BMBS; Matire Harwood, MBChB; Brian Cox, PhD; Mark Weatherall, FRACP; Lutz Beckertz, MD; Anna Hansell, PhD; Alison Prithchard; Geoffrey Robinson, FRACP; and Richard Beasley, DSc. The study was conducted on behalf of the Cannabis and Respiratory Disease Research Group.

AAO-HNS will join in observing Oral, Head, and Neck Cancer Awareness Week (OHNCAW) beginning April 21, 2008 and ending April 27, 2008. More information on the week's activities can be found at http://www.headandneck.org/.

About the AAO-HNS

The American Academy of Otolaryngology - Head and Neck Surgery (http://www.entnet.org/), one of the oldest medical associations in the nation, represents more than 13,000 physicians and allied health professionals who specialize in the diagnosis and treatment of disorders of the ears, nose, throat, and related structures of the head and neck. The Academy serves its members by facilitating the advancement of the science and art of medicine related to otolaryngology and by representing the specialty in governmental and socioeconomic issues. The organization's mission: "Working for the Best Ear, Nose, and Throat Care."

Source: Jessica Mikulski
American Academy of Otolaryngology, Head and Neck Surgery




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...